Qing Tian

851 citations
34 papers · 604 indexed · h-index 12
Topics
Diabetes Treatment and Management (10 papers)Pancreatic function and diabetes (6 papers)Metabolism, Diabetes, and Cancer (5 papers)

In The Last Decade

Qing Tian

34 papers receiving 592 citations

Peers

Qing Tian
Comparison fields: 5 of 75
  • Endocrinology, Diabetes and Metabolism 258
  • Molecular Biology 230
  • Surgery 142
  • Oncology 66
  • Epidemiology 66
Replace Arif Şanlı with:
Arif Şanlı Türkiye
Mouna Mnif Tunisia
Eddie Myers Ireland
Yehai Liu China
Bengü Çobanoğlu Türkiye
Masashi Ishikawa Japan
Maria Grazia Petrillo Italy
Anna La Mura Italy
Maria Gisele Matheus United States
Qing Tian relative to Arif Şanlı Türkiye Arif Şanlı's profile →
Citations per field
00.5×7.3×
Arif Şanlı · 1×
Citations per year

Countries citing papers authored by Qing Tian

Since Specialization
Citations

This map shows the geographic impact of Qing Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Tian more than expected).

Fields of papers citing papers by Qing Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Tian. The network helps show where Qing Tian may publish in the future.

Co-authorship network of co-authors of Qing Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Tian. A scholar is included among the top collaborators of Qing Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Tian. Qing Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 3
4 5
5 2
6 64
7 5
8 24
9 31
10 9
11 54
12
[Neonatal diabetes mellitus caused by KCNJ11 mutation: a case report].
1
13 4
14 21
15
Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury.
44
16 8
17
[Role of serine/threonine protein phosphatase in tau phosphorylation].
1
18 4
19 7
20 9

About Qing Tian

Qing Tian is a scholar working on Endocrinology, Diabetes and Metabolism, Sensory Systems and Neurology, having authored 34 papers that have together received 604 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (258 citations), Sensory Systems (37 citations) and Ophthalmology (55 citations). Qing Tian has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Tianpei Hong, Jin Yang, Rui Wei, Ye Liu, Fred H. Linthicum, Haining Wang, Jing Ke, Chenggang Liu, Yang Yang and Bo Zhou. Their work appears in journals such as JAMA, PLoS ONE and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026